The Clorox Company

CLX Consumer Defensive · Household & Personal Products
Delayed 15 min
Last close
$97.09
Jun 29, 2026
52-week range
$84.70 — $132.03
-26% from high
Market cap
11.7B
Diluted basis
Dividend yield
509.0%
P/E
15.8
Trailing
Filing.fyi verdict · Jun 29, 2026

Fairly valued.

Fairly Valued (Neutral) — Filing.fyi's reading derived from the latest 10-K and forensic scores.

Neutral
RED DEEP / 100
Composite Health
AI synthesis · grounded in this ticker's SEC filings · drag to highlight, releases the composer

What the filing actually says.

AI · wry-editorial preset

The Clorox Company’s most recent 10-Q, filed April 30, 2026, presents a document primarily focused on the procedural aspects of corporate reporting. Item 4, “Controls and Procedures,” notes that the Chief Executive Officer and Chief Financial Officer concluded the Company’s disclosure controls and procedures (mechanisms ensuring timely and accurate information reporting) were effective as of the reporting period’s end. This conclusion indicates management’s confidence that required information is recorded, processed, summarized and reported within the time periods specified by SEC rules, a standard but critical affirmation for financial statement users.

This reading, however, is limited by the absence of key forensic scores. The Beneish M-Score (Beneish, 1999), an eight-ratio earnings-manipulation detector, is not available. Similarly, Altman’s Z″ (Altman, 1968), a bankruptcy-distress index, is not provided, preventing an assessment of financial health through that lens. The Piotroski F-Score (Piotroski, 2000), a nine-point fundamental strength scan, is also missing, as is the Fog Index (Gunning, 1964), a readability score where 18+ suggests obfuscatory prose. The lack of these calculated metrics means this specific analysis cannot apply these established screens for potential financial or textual red flags.

The MD&A excerpts provided are concise, directing readers to the prior 10-K for a fuller discussion of financial condition and results of operations. The emphasis on Item 4, Controls and Procedures, underscores the importance of reliable internal systems for financial reporting. While a routine disclosure, management’s explicit statement of effectiveness provides a baseline assurance that the company’s internal mechanisms for generating and disclosing financial data are functioning as intended, a foundational element for any subsequent financial analysis.

Ultimately, this reading of the CLX 10-Q is constrained by the limited excerpts provided, which focus almost exclusively on disclosure controls rather than financial performance or operational risks. Without the calculated forensic scores or more extensive MD&A and risk factor passages, this analysis cannot offer insights into specific financial trends, potential manipulation signals, or the company’s fundamental strength or readability. It merely confirms management’s assertion regarding their reporting infrastructure. Read the 10-Q. Decide for yourself.

SEC filings · last 12 months

Filing timeline

View all on EDGAR →
  • Apr 30, 2026
    10-Q
    Quarterly report (2026-03-31)Period: 2026-03-310
    Read →
  • Apr 30, 2026
    8-K
    Material event (2026-04-30)### Item 2.02 Results of Operations and Financial Condition On April 30, 2026 , The Clorox Company issued a press release announcing its financial results for i0
    Read →
  • Apr 1, 2026
    8-K
    Material event (2026-04-01)### Item 7.01 Regulation FD Disclosure On April 1, 2026, The Clorox Company (“Clorox”) issued a press release announcing the closing of the previously announced0
    Read →
  • Mar 10, 2026
    8-K
    Material event (2026-03-06)### Item 1.01 Entry into a Material Definitive Agreement On March 6, 2026, in connection with the purchase of all of the issued and outstanding membership inter0
    Read →
  • Oct 7, 2025
    DEF 14A
    Proxy statement (2025-11-19)0
    Read →
  • Aug 8, 2025
    10-K
    Annual report (2025-06-30)Period: 2025-06-300
    Read →
Member feature · Custom Q&A
Ask anything about CLX's filings.
Plain-English answer, cited from the company's own 10-K and recent 10-Qs. No buy/sell advice.
Ask a question →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →
Quality of Earnings

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →